Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy - Liimatainen, Suvi; Peltola, Maria; Sabater, Lidia; Fallah, Mahdi; Kharazmi, Elham; Haapala, Anna‐Maija; Dastidar, Prasun; Knip, Mikael; Saiz, Albert; Peltola, Jukka (Epilepsia (Copenhagen), 2010)
Keywords: Adolescent; Adult; Age Distribution; Aged; Anticonvulsants. Antiepileptics. Antiparkinson agents; Autoantibodies - blood; Autoantibodies - cerebrospinal fluid; Autoantibodies - immunology; Autoimmune Diseases - blood; Autoimmune Diseases - diagnosis; Autoimmune Diseases - immunology; Biological and medical sciences; Blotting, Western; Epilepsy - blood; Epilepsy - cerebrospinal fluid; Epilepsy - immunology; Epilepsy, Temporal Lobe - blood; Epilepsy, Temporal Lobe - immunology; Female; Genetic Markers; Glutamate Decarboxylase - blood; Glutamate Decarboxylase - immunology; Glutamic acid decarboxylase antibody; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy; Humans; Immune system; Immunohistochemistry; Male; Medical sciences; Middle Aged; Nervous system (semeiology, syndromes); Neurology; Neuropharmacology; Pharmacology. Drug treatments; Polyendocrinopathies, Autoimmune - diagnosis; Polyendocrinopathies, Autoimmune - immunology; Polyendocrinopathy; Radioimmunoassay; Temporal lobe epilepsy; Human; Glutamic acid; Nervous system diseases; Aminoacid; Central nervous system disease; Complex partial epilepsy; Temporal lobe epilepsy; Polyendocrinopathy; Glutamic acid decarboxylase antibody; Cerebral disorder; Immune system